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Obesity

Commentary

IGF1 and Adipose Tissue Homeostasis
Jacqueline M. Stephens

A new study by Chang et al. published in this issue of Obesity
examines the role of regulation and function of insulin-like growth
factor-1 (IGF1) in adipose tissue (1). Although the majority of circulating IGF1 comes from liver (2), several studies in the past decade
have suggested that IGF1 modulates adipocyte development and
function in vitro (3-5). Yet the contribution of IGF1 to adipogenesis
and fat cell function in the whole animal is poorly understood.
Based on their initial observation that IGF1 expression is increased
in adipose tissue macrophages (ATM) in obese conditions, the Ferrante group followed up on this striking data and examined the role
of IGF1 in both fat cells and macrophages in adipose tissue.
The generation of two animal models revealed that the loss of IGF1
in either Lys2 expressing cells or adiponectin expressing cells
revealed no prominent changes in adipose tissue development or
glucose metabolism. In obese mice, IGF1 levels are decreased in
adipocytes but increased in ATMs. In another model of murine obesity, enhanced IGF1 expression in ATMs has also been observed
(6). Clearly, IGF1 is differentially regulated in adipocytes and macrophages in white fat. However, the end result is no substantial
changes in overall expression of IGF1 in obesity due to the
increased recruitment of ATMs. To effectively demonstrate this differential IGF1 regulation, clodronate was used to deplete ATMs.
Macrophage depletion in lean adipose tissue showed no decrease in
IGF1 since adipocytes are the primary source of adipose tissue
IGF1, but a 75% reduction in IGF1 expression was observed in
obese adipose tissue.
Collectively, these results clearly demonstrate that a robust regulatory system exists to modulate IGF1 levels in adipose tissue. So
what is IGF doing in adipose tissue if it is not regulating adipose tissue development or glucose homeostasis? The animal models used
in this study revealed that ATM-derived IGF1 maintains fat mass
following a cold challenge, whereas adipocyte-derived IGF1 remodels gonadal but not subcutaneous fat, in the context of high-fat feeding. The studies in this article appear to be carefully conducted and
the results are convincing. Previous studies also have revealed

depot-specific differences in IGF1 action in subcutaneous and visceral fat (7). Of note, an additional provocative observation from
this Ferrante study reveals cold-challenged mice do not have an
increase in tyrosine hydoxlyase in ATMs, as has recently been
shown (8).
Overall, this comprehensive study by the Ferrante group reveals
compensatory regulation by macrophages in adipose tissue to maintain IGF1 levels in conditions of obesity and underscores the importance of examining various adipose tissue depots based on differential responses observed in gonadal fat in mice lacking adipocyte
IGF1. This study not only highlights the complexity of hormone
action, but justifies the importance of examining contributions of
individual cell types in adipose tissue as well as location of adipose
tissue depots. I suggest that you read this paper with your trainees
as there is a lot to discuss.O
C 2015 The Obesity Society
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